Type 2 Diabetes Clinical Trial
Official title:
Validation of an Integrated Attention Model for Patients With Type 2 Diabetes
Abstract: Empowerment interventions for chronic diseases are an evolving process. No
agreement exists regarding the necessary components and methodologies to be applied.
Systematic reviews have assessed the effect of self-management interventions. Improvements in
illness beliefs, adherence to drug therapy and glucose monitoring have been reported. In the
long term, no major changes have been achieved in weight, physical activity, smoking status,
and depression scores.
There is a need for additional studies. The Center for Comprehensive Care of Patients with
Diabetes (CAIPaDi) program is an intervention designed to provide education and empowerment
techniques (using simple low-cost interactive tools) over a short period of time followed by
at-distance support using internet or cell phone technology. The target population consists
of patients with type 2 diabetes, free of chronic complications who are non-smokers. The
intervention is composed of four monthly visits followed by a continuous at-distance support
system. At each visit, patients stay for six hours in the center. Information is presented in
group sessions. Empowerment techniques are applied during individual exchanges with the team
or during facilitated group sessions. In summary, empowerment programs are an unmet need in
many healthcare services.
1. Background: There are major deficiencies in the attention quality provided to people
with diabetes in Mexico. The percentage of compliance of therapeutic objectives is
noticeably lower than the one informed in developed countries. It is required to have
structured management strategies, adapted to traits of our population, which allow
improving attention quality in the medium term. The National Institute of Medical
Sciences and Nutrition Salvador Zubirán (INCMNSZ) developed an integrated management
program by using the best evidence available. The target population is people with type
2 diabetes, with less than 5 years with the diagnosis, and is free from chronic
complications. Selection criteria allow the intervention benefit to diminish incidence
of chronic complications.
2. Hypothesis: "The management strategy applied at the Center of Comprehensive Care for the
Patient with Diabetes (CAIPaDi) allows achieving the international treatment standards
(proposed by NCQA) in a two-year period".
3. General and Specific objectives:
General objective: To quantify the results one year after starting the integrated
management program oriented to self-care activities applied at CAIPaDi.
Specific objectives:
- To measure the program impact (after 4 months, one and two years) based on the
following variables: self-care (measured with standardized questionnaires),
efficacy parameters (HbA1c, fasting glycemia, blood lipids, arterial pressure and
use of anti-platelet aggregates), execution parameters (compliance of evaluations
and preventive measures such as the search for microalbuminuria, ophthalmologic
check, influenza vaccination, among others), incidence of micro- and macrovascular
complications of diabetes, hospitalizations, use of emergency service or unforeseen
expenses related to diabetes.
- To compare the efficacy and execution parameters of the cases attended at the
center, with patients with similar characteristics attended at the "Internal
Medicine" service of the INCMNSZ.
- To carry out a study of the social-economic impact of the intervention.
4. Goals: It is intended to validate an intervention that provides integrated attention to
people with diabetes, in order to generate in the patient and his/her family, the
competencies required for self-care in the long term and the prevention of chronic
characteristics. Intervention is low-cost. This characteristic, along with the
intervention systematization will allow the model to be exportable to the first-contact
units.
5. Scientific Methodology: CAIPaDi has the mission of improving quality of life of patients
with diabetes by means of an intervention adapted to the needs of patients, applying
step-by-step action programs".
Intervention consists of four monthly visits, each one being 6 hours long. The visits
have individual and group sessions. The nine specialists in the multidisciplinary team
are endocrinologists, diabetes educator, nutritionists, psychologist, dentists,
psychiatrist, specialist in physical activity, ophthalmologist and foot care. Some of
the functions may be fulfilled by the same health professional, previously trained.
At each session, standardized actions are applied, which are assessed with preset
indicators. At the initial and at yearly visits the following laboratory tests are
taken: glycated hemoglobin, blood chemistry, lipid profile, liver function tests,
albumin-creatinine index in an isolated urine sample, and 12-deviation
electrocardiogram. At the yearly visits the patients receive reinforcement and treatment
modifications as needed.
Contact is kept with patients via phone calls, e-mails and messages on the mobile phone.
Patients are asked to send their assessments on preset dates. Materials and tools are
developed, which allow measuring information from the study in real time, empowerment of
patients and decision-making by the multi-disciplinary team, based on clinical practice
guidelines.
There will be information from 1200 patients with 2-year follow-up. Besides having
information from 1200 additional cases with follow-up at one year, and other 1200 others
with assessments at 6 months. Therefore, the population for assessing execution
variables shall be of 3600 participants. Such sample size allows us to detect
differences higher than 5% in the percentage of cases that comply with the therapeutic
objectives by comparing them with the initial assessment. As a secondary analysis,
results will be compared with the population that receives attention the "Internal
Medicine" service in the INCMNSZ (n=300 subjects).
Patients will be referred from clinics or first contact physicians outside the
Institute.
6. Expected impacts at medium and long term: This proposal allows validating the
intervention designed and applied at CAIPaDi. In case of demonstrating its usefulness
and cost-effectiveness, intervention will be exported to first-contact units. Manuals
and tools have been developed which will allow the implementation of the program with
minimum resources. Such action will allow creating a network of health units that
operate with the same quality standards as INCMNSZ.
7. Infrastructure available at the participating institutions: The INCMNSZ has an area
where the center operates.
8. Deliverable results: Procedure manuals for each of the actions included in the
intervention, tools for decision making based on clinical practice guidelines which will
be patented, educational materials designed for empowering patients (patentable
products), an internet portal, an electronic file, a database, articles in high impact
magazines, diploma courses for generating specific competencies related to diabetes
treatment and to the center management.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |